1
|
Aziz C, Morales A, Pinto W, Fanchini V, Dell Aquila L, Sangaleti C, Elias R, Dalboni M. Evaluation of IL-6, FoxP3 Treg lymphocytes, intestinal barrier biomarkers and the use of synbiotics in obese adolescents: a pilot study. Front Pediatr 2023; 11:1215793. [PMID: 37859769 PMCID: PMC10583575 DOI: 10.3389/fped.2023.1215793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Accepted: 09/19/2023] [Indexed: 10/21/2023] Open
Abstract
Aim This prospective pilot study evaluated inflammatory and intestinal barrier biomarkers and the effects of a synbiotic in obese adolescents. Methods Eighteen obese and 20 eutrophic adolescents were evaluated for body composition using bioimpedance analysis (BIA), body mass index (BMI), IL-6 and lipopolysaccharide (LPS) serum levels, CD4 and FoxP3 Treg lymphocytes and monocytes. Synbiotic supplementation for 60 days was also evaluated for these parameters only in obese adolescents. Results We observed an increase in CD4 lymphocyte (18.0 ± 12.4 vs. 8.9 ± 7.5; p < 0.01), IL-6 (0.30 ± 0.06 vs. 0.20 ± 0.06; p = 0.02) and LPS (0.18 ± 0.15 vs. 0.08 ± 0.05; p < 0.01) levels in obese compared to eutrophic adolescents. After synbiotic supplementation, FoxP3 Treg lymphocytes increased (14.0 ± 6.7 vs. 9.9 ± 5.4; p = 0.02) in obese adolescents. Conclusions Obese adolescents presented a state of microinflammation and intestinal barrier breakdown, and synbiotic supplementation increased the expression of FoxP3 Treg lymphocytes, an anti-inflammatory regulator. Whether the increase in FoxP3 Treg lymphocytes may have an impact on inflammation and outcomes in obese adolescents deserves further evaluation.
Collapse
Affiliation(s)
- Cylmara Aziz
- Department of Postgraduate Studies in Medicine, Universidade Nove de Julho, São Paulo, Brazil
| | - Armando Morales
- Department of Postgraduate Studies in Medicine, Universidade Nove de Julho, São Paulo, Brazil
| | - Walter Pinto
- Department of Postgraduate Studies in Medicine, Universidade Nove de Julho, São Paulo, Brazil
| | - Vanessa Fanchini
- Department of Postgraduate Studies in Medicine, Universidade Nove de Julho, São Paulo, Brazil
| | - Luis Dell Aquila
- Department of Postgraduate Studies in Medicine, Universidade Nove de Julho, São Paulo, Brazil
| | - Carine Sangaleti
- Department of Postgraduate Studies in Nanosciences and Biosciences, Universidade Estadual do Centro Oeste, Guarapuava, Brazil
| | - Rosilene Elias
- Department of Postgraduate Studies in Medicine, Universidade Nove de Julho, São Paulo, Brazil
| | - Maria Dalboni
- Department of Postgraduate Studies in Medicine, Universidade Nove de Julho, São Paulo, Brazil
| |
Collapse
|
2
|
Brito RBDO, Rebello JF, Grabulosa CC, Pinto W, Morales A, Elias RM, Moyses RMA, Dalboni MA. 25-vitamin D reduces inflammation in uremic environment. Sci Rep 2020; 10:128. [PMID: 31924826 PMCID: PMC6954254 DOI: 10.1038/s41598-019-56874-1] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Accepted: 09/23/2019] [Indexed: 01/12/2023] Open
Abstract
Chronic kidney disease (CKD) is characterized by loss of renal function and a consequent increase of serum uremic toxins, which contribute to inflammation status. Deficiency of 25-vitamin D, often found in patients with CKD, has been included as an inflammatory factor since it might modulate the immune system. The aim of this study was to investigate the role of 25-vitamin D on inflammatory pathways in healthy and uremic environment. Toll-like receptor 4 (TLR4), oxidative stress (ROS), vitamin D receptor (VDR), 1-α hydroxylase (CYP27), 24 hydroxylase, cathelicidin, and MCP-1 were evaluated in monocytes exposed to a uremic serum pool compared with healthy pool. The human monocytes lineage (U937) was incubated with or without 25-vitamin D (50 ng/ml for 24 hours). TRL4, VDR, CYP27, CYP24, and ROS were evaluated by flow cytometry. We used ELISA to measure IL-6, TNF-α, IL-10, cathelicidin, and MCP-1 in the cell culture supernatant. We observed a higher expression of TRL-4, IL-6, TNF-α, IL-10, cathelicidin and MCP-1 in monocytes incubated with uremic serum when compared with serum from healthy individuals. Supplementation of 25-vitamin D was able to reduce the expression of TRL4, cathelicidin, and MCP-1 in the uremic environment. There was no difference in the expression of VDR, CYP27 and CYP24 intracellular enzymes. This in vitro study showed that the uremic pool activates inflammatory response in monocytes, which was reversed by 25-vitamin D supplementation; this finding suggests that 25-vitamin D has an anti-inflammatory role in the uremic environment.
Collapse
Affiliation(s)
| | | | | | - Walter Pinto
- Universidade Nove de Julho, UNINOVE, Sao Paulo, Brazil
| | | | - Rosilene Motta Elias
- Universidade Nove de Julho, UNINOVE, Sao Paulo, Brazil.,Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil
| | - Rosa Maria Affonso Moyses
- Universidade Nove de Julho, UNINOVE, Sao Paulo, Brazil.,Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil
| | | |
Collapse
|
3
|
Engrola S, Richard N, Lopes AF, Pinto W, Conceição LEC. Linking weaning success to larval digestive capacity using radiolabelled peptide fractions. Commun Agric Appl Biol Sci 2013; 78:115-118. [PMID: 25141642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
4
|
Pinto W, Diogo P, Martins G, Martínez-Páramo S, Gavaia P, Conceição L, Dias J. Can dietary phospholipid and trace mineral supplementation influence zebrafish reproductive performance? Commun Agric Appl Biol Sci 2013; 78:368-371. [PMID: 25141714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
5
|
Richard N, Engrola S, Palma P, Pinto W, Simes D, Conceição L. Assessment of protein digestive capacity and utilisation during ontogeny of Senegalese sole larvae: a tracer study using in vivo produced radiolabelled peptide fractions. Commun Agric Appl Biol Sci 2013; 78:396-397. [PMID: 25141722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
6
|
Peg V, Espinosa-Bravo M, Vieites B, Vilardell F, Antúnez JR, de Salas Sancho M, Sansano I, Delgado SJJ, Pinto W, Gozalbo F, Petit A, Rubio I. Abstract P1-01-29: Intraoperative molecular analysis of sentinel lymph node as a new predictor of axillary status in early breast cancer patients. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p1-01-29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
The one-step nucleic acid amplification (OSNA) assay (Sysmex Corporation, Kobe, Japan) is a new diagnostic device that uses molecular biological techniques to analyze sentinel lymph node (SLN). Intraoperative SLN assessed by OSNA has been validated as an accurate method for detection of SLN metastasis compared to conventional histological examination. Although recent reports have shown that breast cancer patients with <2 positive SLNs can be spared of a complete axillary lymph node dissection (cALND), there are still a number of patients for whom prediction of non SLN metastasis may be helpful for cALND decision making.
The aim of the present study is to assess the intraoperative positive SLN total tumor load (TTL, defined as the amount of CK19 mRNA copies [copies/μL] in all positive SLNs) obtained by OSNA and to determine whether it is predictive of non-SLNs metastasis independently of the number of affected SLN and the type of surgery.
Data were collected during the month of June 2012 from medical records and include age, tumor size and grade, estrogen and progesterone receptor status, HER2 status, Ki67, presence of lymphovascular invasion (LVI), total number of SLN and non-SLN, number of positive and negative non-SLN, size of SLN and non-SLN metastasis, and TTL in each SLN. A total number of 701 patients were recruited, of which 697 (99,4%) met the study selection criteria. Univariate logistic regression showed that, in addition to TTL (p < 0,001), the number of affected SLNs (p < 0,001), tumor size (p < 0,001), HER2 status (p = 0,007), and LVI (p < 0,001) were predictive of ALND status. The multivariate logistic regression analysis showed that TTL is an independent predictor of metastatic non-SLNs, after adjusting for the tumor size, HER2 status, LVI and, in particular, the number of affected SLNs.
Moreover, the ROC curve analysis showed that, as compared to the number of affected SLN, TTL has a better ROC curve, as measured by the AUC: LogTTL 0.709 (95% CI, 0.667–0.760); number of affected SLN 0.610 (95% CI, 0.570–0.652), p < 0.001. Furthermore, in patients possessing a TTL<15000, the frequency of non-SLN metastasis was 14,7% (NPV = 85,3%, PPV = 41,1%, Sensitivity = 76,7%, Specificity = 55,2%). Taking this value as a cutpoint, 85 patients with mastectomy may have spared a cALND considering the predictive results of the TTL. In seven patients with > 3 positive SLN the TTL was < 15000 so this group, even with 3 positive SLNs, have 14.7% of having additional non SLN metastasis.
In conclusion, TTL by OSNA is a newly standardized, automated, and reproducible tool that predicts axillary node status better and independently of the number of affected SLNs and the type of surgery. This value can then help clinicians to personalize surgical treatment. Prospective studies will be carried out to determine the clinical impact of this variable in the management of patients.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P1-01-29.
Collapse
Affiliation(s)
- V Peg
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - M Espinosa-Bravo
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - B Vieites
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - F Vilardell
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - JR Antúnez
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - M de Salas Sancho
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - I Sansano
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - Sánchez JJ Delgado
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - W Pinto
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - F Gozalbo
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - A Petit
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - I Rubio
- Hospital Universitario Vall d'Hebron, Barcelona, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain; Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain; Complejo hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Hospital Universitario de Salamanca, Salamanca, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Universitario e Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain; Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| |
Collapse
|
7
|
dos Santos Aguiar S, de Jesus Girotto Zambaldi L, dos Santos AM, Pinto W, Brandalise SR. Comparative genomic hybridization analysis of abnormalities in chromosome 21 in childhood osteosarcoma. ACTA ACUST UNITED AC 2007; 175:35-40. [PMID: 17498555 DOI: 10.1016/j.cancergencyto.2007.01.007] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2006] [Revised: 12/18/2006] [Accepted: 01/08/2007] [Indexed: 12/23/2022]
Abstract
Osteosarcomas (OS) are aggressive tumors of the bone and often have a poor prognosis. The tumors exhibit karyotypes with a high degree of complexity, which has made it difficult to determine whether any recurrent chromosomal aberrations characterize OS. To address inherent difficulties associated with classical cytogenetic analysis, comparative genomic hybridization (CGH) was applied to OS tissue. Forty-one pediatric OS specimens were analyzed by a CGH technique: 24 female and 17 male patients, with a median age of 12 years and 4 months. Chromosomal abnormalities were highly diverse and variable, including gains of chromosome 1p, 2p, 3q, 5q, 5p, and 6p and losses of 14q (50% in 14q11.2), 15q, and 16p. A high level of losses of chromosome 21 was present (26/41 cases; P = 0.008), most often loss of the 21q11.2 approximately 21 region. These novel findings in chromosome 21 of pediatric OS tumors suggest that specific sequences mapping to these chromosomal regions are likely to play a role in the development of OS.
Collapse
Affiliation(s)
- Simone dos Santos Aguiar
- Pediatric Oncology Department, Centro Infantil Boldrini, Rua Gabriel Porto 1270, Barão Geraldo, Campinas, CEP 13083210, SP, Brazil.
| | | | | | | | | |
Collapse
|
8
|
Gomes MV, Gomes CC, Pinto W, Ramos ES. Methylation pattern at the KvDMR in a child with Beckwith–Wiedemann syndrome conceived by ICSI. Am J Med Genet A 2007; 143A:625-9. [PMID: 17318850 DOI: 10.1002/ajmg.a.31628] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Affiliation(s)
- M V Gomes
- Department of Genetics, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
| | | | | | | |
Collapse
|
9
|
Bertuzzo CS, Pinto W. Molecular screening of CFTR gene in Brazilian men with bilateral agenesis of the vas deferens. HUM FERTIL 2006; 9:53-6. [PMID: 16581722 DOI: 10.1080/14647270500440598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Infertility is a common symptom of cystic fibrosis, especially in men (95% become sterile). It is caused by blockage of the vas deferens and the epididymis, which result in degeneration of the tubules. The purpose of this study was to verify the frequency of CFTR gene mutation in patients with bilateral agenesis of the vas deferens using SSCP and sequencing. The study population consisted of 40 white individuals with agenesis of the vas deferens as well as their 12 siblings without agenesis of the vas deferens. CTFR gene mutation was found in 22 of the 40 patients (55%) and it was possible to detect both mutating alleles in these 22 patients. The most frequent genotype found was ?F508/IVS8-5T. There was no genotype concordance in siblings. Our results show the importance of the investigation of CFTR mutation in patients with vas deferens agenesis.
Collapse
Affiliation(s)
- Carmen Sílvia Bertuzzo
- Department of Genetics, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Sao Paulo, Brazil.
| | | |
Collapse
|
10
|
Abstract
Down syndrome (DS) is a complex genetic and metabolic disorder attributed to the presence of three copies of chromosome 21. The extra chromosome derives from the mother in 93% of cases and is due to abnormal chromosome segregation during meiosis (nondisjunction). Except for advanced age at conception, maternal risk factors for meiotic nondisjunction are not well established. A recent preliminary study suggested that abnormal folate metabolism and the 677 (C-->T) mutation in the methylene-tetrahydrofolate reductase (MTHFR) gene may be maternal risk factors for DS. Frequency of the MTHFR 677 (C-->T) and 1298 (A-->C) mutations was evaluated in 36 mothers of children with DS and in 200 controls. The results are consistent with the observation that the MTHFR 677 (C-->T) and 1298 (A-->C) mutations are more prevalent among mothers of children with DS than controls. In addition, the most prevalent genotype was the combination of both mutations. The results suggest that mutations in the MTHFR gene are associated with maternal risk for DS
Collapse
Affiliation(s)
- Laura Brunelli das Neves Grillo
- Departamento de Genética Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP 13081-970, Brasil
| | | | | | | | | |
Collapse
|
11
|
Curry JL, Pinto W, Nickoloff BJ, Slominski AT. Human keratinocytes express functional alpha-MSH (MC1-R) receptors. In Vitro Cell Dev Biol Anim 2001; 37:234-6. [PMID: 11409689 DOI: 10.1007/bf02577535] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
12
|
Abstract
The hypothalamic-pituitary-adrenal (HPA) axis is the major stress response system. Several components of the HPA axis, such as corticotropin-releasing hormone (CRH) and POMC peptides and their receptors are also present in the skin. In earlier studies, we showed that CRH inhibits cellular proliferation of immortalized human keratinocytes. We now examine further the functional activity of the HPA axis in the skin, by characterizing the actions of CRH on normal foreskin keratinocytes. The CRH receptor was detected as CRH-R1 antigen at 47 kDa in the cultured keratinocytes by Western blotting, and immunohistochemistry demonstrated its presence in the epidermal and follicular keratinocytes. CRH is also biologically active in cultured keratinocytes, where it inhibits proliferation and enhances the interferon-gamma-stimulated expression of the hCAM and ICAM-1 adhesion molecules and of the HLA-DR antigen. These effects were concentration-dependent, with maximal activity at CRH 10(-7) M. Thus, in the keratinocyte, the most important cellular component of the epidermis, CRH appears to induce a shift in energy metabolism away from proliferation activity, and toward the enhancement of immunoactivity. Therefore, similar to its central actions, cutaneous CRH may also he involved in the stress response, but at a highly localized level.
Collapse
Affiliation(s)
- M E Quevedo
- Department of Pathology, Loyola University Medical Center, Maywood, Illinois 60153, USA
| | | | | | | | | |
Collapse
|
13
|
Abstract
This study investigated the effects of prenatal exposure to cocaine on the intracellular kinetics (i.e. rate constant of receptor production and degradation) that govern the maintenance and regulation of cortical 5-HT(1A) and 5-HT(2A) receptor densities in offspring. Adult male rat offspring, prenatally exposed to saline or (-) cocaine (15 mg/kg, s.c., b.i.d, from gestational day 13 through 20), were injected with either vehicle or the irreversible receptor antagonist, EEDQ (10 mg/kg, s.c.), and sacrificed at various post-injection times to monitor the recovery of receptor densities in cerebral cortex. In both saline and cocaine exposed offspring, initial EEDQ-induced reductions (>80%) in 5-HT(1A) and 5-HT(2A) receptor densities were followed by a time-dependent repopulation that reached steady state ([B(max)](ss)) densities comparable to non-EEDQ treated controls by day 10 post-treatment. Calculation of 5-HT(1A) receptor kinetic parameters indicated that prenatal exposure to cocaine did not significantly alter: (1) the receptor production rate (saline: 0.809 fmol/mg protein/h; cocaine: 0.724 fmol/mg protein/h), (2) the receptor degradation rate constant (saline: 0.0063 h(-1); cocaine: 0.0062 h(-1)) or (3) the half-life (t(1/2)) of receptor repopulation (saline: 109.2 h; cocaine: 111.5 h). Similarly, 5-HT(2A) receptor rate constants for production (1. 550 fmol/mg protein/h) and degradation (0.0061 h(-1)) and consequently, t(1/2) (113.2 h), were not significantly altered by prenatal exposure to cocaine. These data suggest that within homogenates of cerebral cortex, prenatal exposure to cocaine did not alter the overall intracellular processes that underlie receptor production or degradation and determine steady state densities of 5-HT(1A) or 5-HT(2A) receptors.
Collapse
Affiliation(s)
- A Vicentic
- Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago, Stritch School of Medicine, 2160 South First Avenue, Maywood, IL 60153, USA
| | | | | | | |
Collapse
|
14
|
Abstract
The present study investigates the age-dependent effects of prenatal cocaine exposure on changes in the neurochemical and functional status of brain serotonin neurons. Pregnant rats were administered either saline or (-)cocaine HCl (15 mg/kg, subcutaneously), twice daily from gestational days 13 through 20. Neurochemical changes in frontal cortex, hypothalamus, hippocampus, striatum and midbrain of prepubescent and adult offspring were determined by measuring: (1) the content of serotonin (5-HT) and its major metabolite 5-hydroxyindolacetic acid (5-HIAA), and (2) the ability of the serotonin releasing drug p-chloroamphetamine (PCA) to reduce brain serotonin levels. Brain catecholamine content was determined in progeny for comparative purposes. Prior to maturation, prenatal exposure to cocaine did not alter basal levels of brain 5-HT or 5-HIAA in any brain region examined. However, in adult progeny prenatally exposed to cocaine, basal 5-HT content was significantly reduced in the frontal cortex (-32%) and hippocampus (-40%), suggesting maturation-dependent effects of prenatal cocaine exposure on brain 5-HT neurons. Consistent with the maturational onset of changes in 5-HT, striatal dopamine was significantly reduced (-10%) by prenatal exposure to cocaine only in adult offspring. Reductions in 5-HT in most brain regions, produced by pharmacological challenge with p-chloroamphetamine (PCA), were comparable in prenatal saline versus cocaine offspring. One notable exception was the markedly greater reduction (-40%) in 5-HT in the midbrain of immature offspring prenatally exposed to cocaine, suggesting alterations in midbrain 5-HT neurons prior to maturation. Overall, these data demonstrate prenatal cocaine exposure produces region-specific changes in 5-HT neurons in offspring with some deficits occurring only following maturation.
Collapse
Affiliation(s)
- T M Cabrera-Vera
- Department of Pharmacology and Experimental Therapeutics, Loyola University of Chicago, Stritch School of Medicine, 2160 South First Avenue, Maywood, IL 60153, USA
| | | | | | | |
Collapse
|
15
|
Battaglia G, Cabrera-Vera TM, Van de Kar LD, Garcia F, Vicentic A, Pinto W. Prenatal cocaine exposure produces long-term impairments in brain serotonin function in rat offspring. Ann N Y Acad Sci 1998; 846:355-7. [PMID: 9668423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- G Battaglia
- Department of Pharmacology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153, USA.
| | | | | | | | | | | |
Collapse
|
16
|
Cabrera-Vera TM, Garcia F, Pinto W, Battaglia G. Effect of prenatal fluoxetine (Prozac) exposure on brain serotonin neurons in prepubescent and adult male rat offspring. J Pharmacol Exp Ther 1997; 280:138-45. [PMID: 8996191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
The present study examines the consequences of prenatal fluoxetine exposure on brain serotonin [5-hydroxytryptamine (5-HT)] neurons in male offspring. Pregnant rats were administered either saline or fluoxetine (10 mg/kg s.c.) daily from gestational day 13 through gestational day 20. The biochemical status of brain 5-HT neurons was assessed in prepubescent and adult offspring by measuring 1) the 5-HT and 5-hydroxyindoleacetic acid content, 2) the density of [3H]paroxetine-labeled 5-HT uptake sites and 3) the ability of the 5-HT-releasing drug p-chloroamphetamine to reduce 5-HT content. Biochemical parameters were assessed in the frontal cortex, hypothalamus, hippocampus, striatum and midbrain. Comparative effects on dopamine and norepinephrine content in selected regions were also determined. Prenatal exposure to fluoxetine significantly reduced (-28%) 5-HT content in the frontal cortex of prepubescent but not adult male offspring. In contrast, in adult progeny prenatal fluoxetine exposure produced a significant decrease only in midbrain 5-HT content (-28%). In addition, p-chloroamphetamine markedly reduced 5-HT content in all brain regions examined, but the ability of p-chloroamphetamine to reduce 5-HT content was significantly attenuated only in the midbrain of adult progeny prenatally exposed to fluoxetine. No significant differences were observed between control and fluoxetine-exposed progeny with respect to brain 5-hydroxyindoleacetic acid content, the 5-hydroxyindoleacetic acid/5-HT ratio or the density of 5-HT uptake sites, regardless of the brain region examined or the age of the offspring. These data provide additional evidence that prenatal exposure to fluoxetine can produce limited, rather than global, changes in brain 5-HT neurons in male rat offspring and that the effects observed are region-specific and age-dependent. The potential functional consequences and clinical implications of these alterations in brain 5-HT systems remain to be elucidated.
Collapse
Affiliation(s)
- T M Cabrera-Vera
- Department of Pharmacology and Experimental Therapeutics, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois, USA
| | | | | | | |
Collapse
|
17
|
Pinto W, Battaglia G. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation. Mol Pharmacol 1994; 46:1111-9. [PMID: 7808431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
The present study investigates the comparative repopulation kinetics of 5-hydroxytryptamine (5-HT)1A, 5-HT1B, and 5-HT2A receptors in rat cortex homogenates after irreversible receptor inactivation by N-ethoxycarbonyl-1,2-ethoxydihydroquinoline. Adult male rats were administered a single subcutaneous dose of vehicle (1:1 ethanol/water) or N-ethoxycarbonyl-1,2-ethoxydihydroquinoline (10 mg/kg), and the recovery of 5-HT receptor subtypes was measured at various times after injection (4-336 hr). Despite comparable control Bmax values for 5-HT1A (84 +/- 2 fmol/mg of protein) and 5-HT1B (94 +/- 4 fmol/mg) subtypes, marked differences were noted in their 1) receptor production rates (r = 0.349 versus 0.235 fmol/mg of protein/hr), 2) receptor degradation rate constants (k = 0.0056 versus 0.0033 hr-1), and 3) half-lives of receptor recovery (124.1 versus 212.5 hr). For 5-HT2A receptors, both r and k for agonist [(+/-)-1-(2,5-dimethoxy-4-[125I]iodophenyl)-2-aminopropane]- or antagonist ([3H]ketanserin)-labeled sites were markedly greater than the respective values for the 5-HT1 subtypes. In addition, the significantly different Bmax values for agonist- versus antagonist-labeled 5-HT2A receptors (79 +/- 4 versus 206 +/- 10 fmol/mg) were reflected exclusively as a 2.6-fold difference in receptor production rates, because degradation rate constants (k) were identical. Moreover, the stoichiometry of agonist-labeled to antagonist-labeled 5-HT2A receptors was not altered at any time point during recovery. These data indicate that 1) comparable receptor steady state Bmax values for 5-HT receptor subtypes may be due to markedly different receptor kinetic parameters (r and k), 2) differences in r and k are greater between 5-HT receptor families (i.e., 5-HT1 versus 5-HT2) than among subtypes within a family (i.e., 5-HT1A versus 5-HT1B), and, 3) despite marked changes in 5-HT2A receptor density, the percentage of receptors in the agonist-labeled, high affinity state is maintained.
Collapse
Affiliation(s)
- W Pinto
- Neuroscience Program, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois 60153
| | | |
Collapse
|
18
|
Abstract
The present study investigates the inactivation and recovery of brain serotonin (5-HT) recognition sites by EEDQ (N-ethoxycarbonyl-2-ethoxy-1,2,-dihydroquinoline). Adult male Sprague-Dawley rats were given a single s.c. injection of vehicle (1:1 EtOH/H2O) or EEDQ (1-20 mg kg-1) and sacrificed at 4 h and 7 days (10 mg kg-1 dose) post-injection. EEDQ dose-dependently reduced the Bmax of 5-HT1A(3H-DPAT),5-HT1B(125I-CYP),5-HT2(3H-ketanserin) and 5-HT2/1C(125I-DOI) receptors in cortical homogenates. In contrast, EEDQ was without effect on the 5-HT transporter recognition site (3H-paroxetine). No significant changes in affinity were observed for 5-HT1B, 5-HT2 or 5-HT2/1C receptors. The rank order of sensitivity to EEDQ inactivation was: 5-HT1A > 5-HT1B > 5-HT2 approximately 5-HT2/1C >>> 5-HT uptake sites. This study demonstrates: (1) differential EEDQ inactivation and recovery of 5-HT receptors and (2) lack of EEDQ inactivation of the 5-HT transporter.
Collapse
Affiliation(s)
- W Pinto
- Neuroscience Graduate Program, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois 60153
| | | |
Collapse
|
19
|
Zweerink MM, Edison AM, Wells GB, Pinto W, Lester RL. Characterization of a novel, potent, and specific inhibitor of serine palmitoyltransferase. J Biol Chem 1992; 267:25032-8. [PMID: 1460005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
We have examined the mechanism of action of two natural products identified as broad spectrum antifungal agents (VanMiddlesworth, F., Dufresne, C., Wincott, F. E., Mosley, R. T., and Wilson, K. E. (1992) Tetrahedron Lett., in press; VanMiddlesworth, F., Giacobbe, R. A., Lopez, M. Garrity, G., Bland, J. A., Bartizal, K., Fromtling, R. A., Polishook, J., Zweerink, M. M., Edison, A. M., Rozdilsky, W., Wilson, K. E., and Monaghan, R. L. (1992) J. Antibiot. (Tokyo) 45, 861-867), designated sphingofungin B (2S-amino-3R,4R,5S,14-tetrahydroxyeicos-6-enoic acid) and sphingofungin C (2S-amino-5S-acetoxy-3R,4R,14-trihydroxyeicos-6-enoic acid), and find they are potent specific inhibitors of serine palmitoyltransferase, which catalyze the committed step of sphingolipid biosynthesis. We used Saccharomyces cerevisiae as a model to investigate the mechanism of the antifungal activity of these compounds. Macromolecular synthesis was not immediately affected by either sphingofungin B or C, synthesis continued for 60-90 min following the addition of drug to growing cultures. Significant loss of viability with sphingofungins required growing cultures and began only after several hours, with greater than 99.9% of drug-treated cells non-viable after 24 h. No lysis or other gross changes in cell morphology were observed in drug-treated cells. The structural similarity of sphingofungin B and C to sphingosine and phytosphingosine prompted us to investigate their effects on sphingolipid synthesis. Nanomolar levels of the drugs inhibited the incorporation of [3H]inositol into sphingolipid before incorporation into the sphingolipid precursor, phosphatidylinositol was affected, suggesting specific inhibition of sphingolipid synthesis. This hypothesis was confirmed by experiments in which the growth inhibitory activity of both drugs was completely ablated by the addition of phytosphingosine, dihydrosphingosine, or ketodihydrosphingosine to the culture medium. Reversal of antifungal activity by ketodihydrosphingosine suggested that serine palmitoyltransferase could be the actual target of these compounds. Direct evidence for this hypothesis was the observation of inhibition of serine palmitoyltransferase activity in crude membrane preparations at nanomolar concentrations of each drug. The potent inhibition of serine palmitoyltransferase coupled with the apparent lack of effect of these compounds on other cellular functions suggests that sphingofungin B and C will prove to be important new tools for studying the role of sphingolipids in yeast and perhaps in other organisms.
Collapse
Affiliation(s)
- M M Zweerink
- Department of Infectious Disease Research, Merck, Sharp, and Dohme Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065
| | | | | | | | | |
Collapse
|
20
|
Toma L, Pinto W, Rodrigues VC, Dietrich CP, Nader HB. Impaired sulphated glycosaminoglycan metabolism in a patient with GM-2 gangliosidosis (Tay-Sachs disease). J Inherit Metab Dis 1990; 13:721-31. [PMID: 2174089 DOI: 10.1007/bf01799575] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
An abnormal urinary excretion of sulphated glycosaminoglycans in a patient with GM-2 gangliosidosis (Tay-Sachs disease) is described. Besides the accumulation of GM-2 ganglioside in liver and lack of hexosaminidase A, the patient shows an abnormal urinary excretion of an iduronic acid-rich low molecular weight heparan sulphate. Also, no dermatan sulphate could be detected in the urine, whereas this compound was the main sulphated glycosaminoglycan in the liver of the patient. Heparan sulphate was the main glycosaminoglycan of normal liver. The total amount of sulphated glycosaminoglycans in the urine and liver of the patient did not differ significantly from the amounts found in the liver and urine of normal subjects. Several plasma glycosidases have been assayed and the activities did not differ significantly from the values obtained for the plasma of normal subjects.
Collapse
Affiliation(s)
- L Toma
- Departamento de Bioquímica, Escola Paulista de Medicina, São Paulo, Brazil
| | | | | | | | | |
Collapse
|
21
|
Toma L, Pinto W, Nader HB, Dietrich CP. Clinical and biochemical changes in a child with type I mucopolysaccharidosis during long-term transfusion of leukocytes. Braz J Med Biol Res 1983; 16:29-33. [PMID: 6227354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
The effect of two years of periodic transfusions at 2--4 month intervals of mixed leukocytes in a patient with Type I mucopolysaccharidosis is described. There was an increase of urinary chondroitin sulfate B after the first transfusion followed by a progressive decrease to 35% of the initial daily excretion. Chondroitin sulfate AC, which was almost absent prior to the transfusions, was excreted in significant amounts after the 4th transfusion. There was a decrease of hepatosplenomegaly, kyphosis and gibbus and no changes in the other signs of the disease. Regarding stature, mental development and social behavior, the patient is developing thus far as a normal child. The early diagnosis of the disease and the immediate transfusions undoubtedly have been contributing factors to the restoration and/or maintenance of the child in an almost normal condition.
Collapse
|
22
|
Abstract
A huge tumor filled the lumen of the urinary bladder in a ten-year-old boy. The tumor had polypoid and papillary components with a variety of glandular structures. Some glands were surrounded by a primitive stroma reminiscent of renal dysplasia, a new finding in adenoma (or mixed hamartoma) of the urinary bladder. A couple of months later a large tumor filling the urinary bladder and with the same microscopic features was diagnosed in his fourteen-year-old brother.
Collapse
|
23
|
Gardner LI, Neu RL, Shah RS, Pinto W, Co M, Lehr ER, Barg GA. Family with three apparently balanced t(3;15) (p27;q22) translocation carriers. Association with deficits in language acquisition and mental retardation: a possible example of position effect in man. Am J Dis Child 1979; 133:1002-5. [PMID: 495587 DOI: 10.1001/archpedi.1979.02130100026004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
A father, son, and daughter had a (3;15) (p27;q22) simple reciprocal translocation. No abnormality in the G-banding pattern was noted. The girl was most severely affected; she had an abnormal phenotype, noticeable delay in receptive and expressive language development, bilateral hearing impairment, and definite mental retardation. The boy had a moderate delay in receptive language skills, had moderate hearing impairment in one ear, and showed mild mental retardation. The father has low-set ears, some deficits in receptive language skills, is illiterate, and was found to be borderline mentally retarded. The mother and younger child do not have the translocation and are normal in terms of phenotype, intellect, and verbal skills. The accumulating evidence suggests that balanced translocations are associated with an increased frequency of intellectual deficit and congenital anomalies, and the cytogenetic mechanism may be that of position effect.
Collapse
|
24
|
Pinto W, Gardner LI, Rosenbaum P. Abnormal genitalia as a presenting sign in two male infants with hydantoin embryopathy syndrome. Am J Dis Child 1977; 131:452-5. [PMID: 403759 DOI: 10.1001/archpedi.1977.02120170078016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Abnormal genitalia was a salient clinical finding in two unrelated male infants with the hydantoin embryopathy syndrome. Both infants also exhibited hypoplastic nails of fingers and toes, hypertelorism, and a flat nasal bridge, and one had severe developmental retardation. We review previously reported cases of the hydantoin embrypathy syndrome and discuss factors possibly affecting the teratogenicity of phenytoin. Male infants with findings such as the patients of this report need to be differentiated from patients with Noonan syndrome and Aarskog syndrome. We suggest that mothers receiving phenytoin who have given birth to one affected infant should be given a different anticonvulsant for future pregnancies.
Collapse
|
25
|
Neu RL, Ortega CC, Barg GA, Pinto W, Gardner LI, Howell WM, Denton TE. Inclusion of satellites in an 18/21 translocation chromosome shown by ammonical-silver staining (sat-banding) in case of partial trisomy 18. J Med Genet 1976; 13:520-2. [PMID: 65472 PMCID: PMC1013484 DOI: 10.1136/jmg.13.6.520] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
A male infant with a partial trisomy 18 and a 46,XY, --21, t(18;21)(18qter replaced by 18q12::21 p13 replaced by 21 qter) chromosome complement is described. The translocation chromosome is of special interest because it includes the satellites of chromosome 21. This was shown by differential satellite staining with the ammoniacal-silver technique.
Collapse
|
26
|
Cézar PC, Mizusaki K, Pinto W, Opromolla DW, Beiguelman B. [S hemoglobin and leprosy (author's transl)]. Rev Bras Pesqui Med Biol 1974; 7:151-67. [PMID: 4849673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
27
|
Beiguelman B, Pinto W, El-Guindy MM, Krieger H. Factors influencing the level of dapsone in blood. Bull World Health Organ 1974; 51:467-71. [PMID: 4549497 PMCID: PMC2366315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
The level of dapsone in the blood 4 and 6 h after the ingestion of the 7th daily dose of 100 mg of the drug was investigated in 36 adult males with leprosy who had normal renal function and were free of diarrhoea and emesis. The bimodal distribution of the dapsone levels at 6 h was shown by multiple regression analysis to be due to a negative correlation between this trait and the haematocrit value. Among the patients with high dapsone blood levels, 81.8% presented haematocrit values under 36%, whereas only 20% of those with low levels showed low haematocrit values. Partial regression coefficients, calculated for the dapsone level on the age, weight of the patient, estimated number of years since the onset of leprosy, number of years under sulfone treatment, and blood levels of haemoglobin, albumin, and globulins, did not show statistical significance.
Collapse
|
28
|
Pinto W, Beiguelman B. [Incidence of illegitimacy and leprosy]. Rev Paul Med 1967; 71:267-70. [PMID: 5620096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
29
|
Beiguelman B, Souza-Campos N, Pinto W. [Genetic factors and effect of BCG vaccination in the Mitsuda reaction]. Rev Paul Med 1967; 71:271-8. [PMID: 5620097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|